Abstract
Leader RNA is found at the 5′ end of the mouse hepatitis virus (MHV) genomic RNA, at the 5′ end of the seven viral mRNAs, and free in the cell. Leader RNA is synthesized by a transcriptional activity separate from the activities that synthesize both (-) sense genomic length RNA and the virus mRNAs1. It is believed to function as a primer, binding to complementary intergenic sites, on (-) sense template, situated 5′ of each of the initiation sites for viral mRNAs2. Using monoclonal antibodies specific for the nucleocapsid (N) protein, immunoprecipitations of RNA/protein complexes from infected cells indicate that the N protein is complexed to: 1) genomic RNA; Z) viral mRNAs; and 3) even free leader containing RNA fragments as small as 60 nucleotides in length3. Northwestern blot analysis showed that the viral N protein exhibits RNA binding activity that is specific for viral leader containing RNA when expressed in the (+) sense4,5. However, this system has several limitations. First, in denaturing conditions, RNA/protein interactions which require the interaction of multiple protein subunits cannot be studied, and second, it is not possible to quantify relative affinities and binding characteristics.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
P. R. Brayton, M. M. C. Lai, C. D. Patton and S. A. Stohlman, J. Virol. 42:847–853 (1982).
R. S. Baric, C. -K. Shieh, S. S. Stohlman and M. M. C. Lai, Virol. 156:342–354 (1987).
R. S. Baric, G. W. Nelson, J. Q. Fleming, R. J. Deans, J. G. Keck, N. Casteel and S. A. Stohlman, J. Virol. 62:4280–4287 (1988).
S. A. Stohlman, R. S. Baric, G. W. Nelson, L. H. Soe, L. M. Welter and R. J. Deans, J. Virol. 62:4288–4295 (1988).
S. G. Robbins, M. F. Frana, J. J. McGowan, J. F. Boyle and K. W. Holmes, Virol. 150:402–410 (1986).
J. Armstrong, S. Smeeken and P. Rottier, Nucl. Acids Res. 11:883-891.
M. M. C. Lai and S. A. Stohlman, J. Virol. 26:236–242 (1978).
E. Jacobs and A. Clad, Anal. Biochem. 154:583–589 (1986).
M. Bradford, Anal. Biochem. 72:248 (1976).
R. Schneider, I. Gander, U. Miller, R. Mertz and E. L. Wennacher, Nucl. Acids Res. 14, 1303–1317.
L. M. Welter, G. Nelsen, S. A. Stohlman and R. J. Deans, Submitted to Nucl. Acids Res. (1986).
M. Zuker and P. Stiegler, NAR 9:133–148 (1981).
M. M. C. Lai, Baric, R. S., Brayton, P. R. and Stohlman, S. A. Proc. Natl. Acad. Sci. USA 81:3626–3630 (1984).
G. J. Murakawa, B. C. Chen, M. D. Kuwabara, D. P. Nierlich and D. S. Sigman, Nucl. Acids Res. In Press.
P. E. Nielsen, C. Jeppesen and O. Buchardt, FEBS Letters 235:122–124 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this paper
Cite this paper
Welter, L.M., Stohlman, S.A., Deans, R.J. (1990). MHV Leader RNA Secondary Structure Affects Binding to the Nucleocapsid Protein. In: Cavanagh, D., Brown, T.D.K. (eds) Coronaviruses and their Diseases. Advances in Experimental Medicine and Biology, vol 276. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5823-7_34
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5823-7_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5825-1
Online ISBN: 978-1-4684-5823-7
eBook Packages: Springer Book Archive